In this issue: CloudKit, airlines, drawing lines, IVF, and biomats.
loved the biotech financial-engineering piece.
maybe biotech securities are fundamentally misdesigned for underlying risk? lots of overlap between biotech & compute futures tbh
loved the biotech financial-engineering piece.
maybe biotech securities are fundamentally misdesigned for underlying risk? lots of overlap between biotech & compute futures tbh